Tania Brandstoetter

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Chronic Myeloid Leukemia

Signaling Pathway

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Tania Brandstoetter, Johannes Schmoellerl, Reinhard Grausenburger, Sebastian Kollmann, Eszter Doma, Jani Huuhtanen, Thorsten Klampfl, Thomas Eder, Florian Grebien, Gregor Hoermann, Johannes Zuber, Mohamed El Missiry, Barbara Maurer, Veronika Sexl
SBNO2 is a critical mediator of STAT3-driven hematological malignancies. Blood (2023)
Tania Brandstoetter, Johannes Schmoellerl, Reinhard Grausenburger, Sebastian Kollmann, Eszter Doma, Jani Huuhtanen, Thorsten Klampfl, Thomas Eder, Florian Grebien, Gregor Hoermann, Johannes Zuber, Mohamed El Missiry, Barbara Maurer, Veronika Sexl
SBNO2 is a critical mediator of STAT3-driven hematological malignancies. Blood (2023)
Sebastian Kollmann, Reinhard Grausenburger, Thorsten Klampfl, Michaela Prchal-Murphy, Klavdija Bastl, Hanja Pisa, Vanessa M Knab, Tania Brandstoetter, Eszter Doma, Wolfgang R Sperr, Sabine Lagger, Matthias Farlik, Richard H Moriggl, Peter Valent, Florian Halbritter, Karoline Kollmann, Gerwin Heller, Barbara Maurer, Veronika Sexl
A STAT5B-CD9 axis determines self-renewal in hematopoietic and leukemic stem cells. Blood 138 (23) (2022)
Grégory La Sala, Camille Michiels, Tim Kükenshöner, Tania Brandstoetter, Barbara Maurer, Akiko Koide, Kelvin Lau, Florence Pojer, Shohei Koide, Veronika Sexl, Laure Dumoutier, Oliver Hantschel
Selective inhibition of STAT3 signaling using monobodies targeting the coiled-coil and N-terminal domains. Nature communications 11 (1) (2020)
Shady Adnan-Awad, Daehong Kim, Helena Hohtari, Komal Kumar Javarappa, Tania Brandstoetter, Isabella Mayer, Swapnil Potdar, Caroline A Heckman, Soili Kytölä, Kimmo Porkka, Eszter Doma, Veronika Sexl, Matti Kankainen, Mohamed El Missiry
Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets. Leukemia 35 (7) (2020)